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ABSTRACT 
 Cognitive bias is a phenomenon that presents in clinical populations where anxious 
individuals tend to adopt a more pessimistic interpretation of ambiguous aversive stimuli and 
depressed individuals not only tend to adopt a more pessimistic interpretation of ambiguous 
aversive stimuli, but also a less optimistic interpretation of ambiguous appetitive stimuli.  Such 
biases have also been pharmacologically reversed in clinical trials.  To measure cognitive bias in 
the chick anxiety-depression continuum  model, chicks exposed to an isolation stressor of 5 min 
to induce an anxiety-like or 60 min to induce a depressive-like state were then tested in a straight 
alley maze to a series of morphed ambiguous appetitive (chick silhouette) to aversive (owl 
silhouette) cues.  In non-isolated controls, runway start and goal latencies generally increased as 
a function of greater amounts of aversive characteristics in the cues.  In chicks in the anxiety-like 
state, runway latencies were increased to aversive ambiguous cues, reflecting more pessimistic-
like behavior. In chicks in the depression-like state, runway latencies were increased to both 
aversive and appetitive ambiguous cues, reflecting more pessimistic-like and less optimistic-like 
behavior, respectively.  The current study sought to be able to pharmacologically reverse this 
cognitive endophenotype which would serve as a further validation step for the model as a 
neuropsychiatric simulation of anxiety and depression.  
 Experiment 1 was conducted to ensure that drug treatments, clonidine and imipramine, do 
not substantially influence cognitive decision making to natural and ambiguous appetitive and 
aversive stimulus cues in the social treatment condition. Experiment 1 consisted of three socially 
tested groups (previous studies have shown that chicks tested with two cagemate conspecifics 
display relatively low levels of stress). Each group was administered either 0.15mg/kg clonidine 
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(tested for 5-min indicative of the anxiety-like phase), 15mg/kg Imipramine (tested for 60-min 
indicative of the depression-like phase), or a physiological saline (tested for 60-min to serve as 
the control) prior to apparatus testing.  Distress vocalizations (DVocs), a dependent measure for 
stress, were collected for each condition. Following apparatus testing, chicks were tested 
immediately in the maze under four stimulus cue conditions: mirror, 25c:75o morph, 75c:25o 
morph: and 0c:100o (owl silhouette). To assess a baseline for each stimulus cue, a no-isolation 
apparatus test control group was administered saline and tested immediately within the maze. 
Dependent measures were start and goal latencies and farthest distance traveled and the maze 
cutoff criterion was 5 min. 
 Although it was not predicted, the patterns of DVocs observed in anxiety-like and 
depression-like phases of socially tested chicks were consistent with previous studies in which 
isolated chicks exhibit a specific pattern of behavioral responses and responses to drug treatment 
in the anxiety-like and depression-like phases. Because differences exist in DVoc rates between 
drug groups for socially treated chicks, it appears that the chicks are experiencing some 
measurable amount of stress even within the social isolation manipulation which may be 
attributable to factors such as novelty to testing apparatus and flock reduction.   
 Consistent with the modest stress patterns observed in the DVoc data, chicks exhibited a 
modest amount of cognitive bias within the maze, more specifically under the ambiguous 
stimulus cues and not the mirror or the owl stimulus cues.  In general, chicks in the depression-
like phase displayed more pessimistic behavior under the aversive and ambiguous aversive 
stimulus cues (25c:75o and 0c:100o) and also less optimistic behavior under the appetitive and 
ambiguous appetitive stimulus cues (mirror and 75c:25o) under mean start latency and mean 
distance traveled.  Both forms of cognitive bias were reversed by imipramine under these two 
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dependent measures.  Although these findings were unexpected, they are consistent with the 
DVoc patterns observed.  Given these unexpected findings the vehicle no-test group was chosen 
to be the main control group for Experiment 2.  
 One additional finding was that for the anxiety-clonidine group, start latencies under the 
mirror, 75c:25o, and 25c:75o stimulus cues were significantly shorter compared to the vehicle 
isolation-test group and mean distance traveled under the 25c:75o stimulus cue was significantly 
shorter compared to the vehicle isolation-test group.  One explanation for these observed effects 
could be that clonidine at a dose of 0.15mg/kg produced observable sedative effects within the 
runway; therefore, the dose of clonidine administered in Experiment 2 was decreased to 
0.10mg/kg to lessen the likelihood of sedation.  
 Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a 
depression-like phase and to test whether those cognitive biases could be pharmacologically 
reversed.  Experiment 2 followed the same procedures as Experiment 1 with three exceptions: 1) 
a new treatment condition, a vehicle 5-min isolation group to use as a control for the anxiety-
clonidine group; 2) lowering the dose of clonidine from 0.15mg/kg to 0.10mg/kg to lessen the 
likelihood of sedation within the runway; and 3) the induction of the isolation produce within the 
testing apparatus.  All dependent measures remained the same. 
 In general, chicks in the depression-like phase displayed more pessimistic behavior under 
the aversive and ambiguous aversive stimulus cues (25c:75o and 0c:100o) and also less 
optimistic behavior under the appetitive and ambiguous appetitive stimulus cues (mirror and 
75c:25o) under mean start latency and mean distance traveled.  Both forms of cognitive bias 
were reversed by imipramine under these two dependent measures. Chicks in the anxiety-like 
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phase displayed more pessimistic behavior under the aversive and ambiguous aversive stimulus 
cues (25c:75o and 0c:100o) under mean start latency. However chicks that were administered 
clonidine tended to display sedation under mean start latency and mean distance traveled despite 
lowering the dose.   
 Collectively, the observation that cognitive biases of both more pessimism and less 
optimism present within the single test paradigm of anxiety and depression and can be 
pharmacologically reversed in the depression-like phase adds to the validity of the chick anxiety-
depression model as a neuropsychiatric simulation. The chick anxiety depression model, along 
with the runway test to ambiguous appetitive and aversive cues, may lend itself to exploring the 
common neurophysiological mechanisms subserving cognitive disturbances and 
pharmacological responses seen in these two seemingly related clinical disorders. 
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Running Head: PHARMACOLOGOCAL REVERSAL OF CONGNITIVE BIAS 
 
Pharmacological Reversal of Cognitive Bias in the  
Chick Anxiety-Depression Continuum Model 
 
Anxiety and depression are two very common and detrimental mental health disorders. 
Anxiety affects approximately 40 million Americans, ages 18 years and older, while depression 
affects 14.8 million Americans (National Institute of Mental Health, 2009a) and 150 million 
people worldwide (World Health Organization, 2003).  Further, with comorbidity rates ranging 
from 50 to 90%, many patients suffer a concurrent presentation of anxiety and depression 
(Kessler, Berglund, Demleer, Jin, Merikangas, & Walters, 2005; Kessler, McGonagle, Zhao, 
Nelson, Hughes, & Eshleman, 1994; R. A. Rivas-Vazquez, Saff-Biller, Ruiz, Blais, A. Rivas-
Vazquez, 2004). Approximately 85% of people suffering from depression will present symptoms 
of anxiety and 90% of people suffering from anxiety will present symptoms of depression 
resulting in even further debilitation (Gorman, 1996-1997). 
  Depression is the primary cause of disability in the United States for ages 15-44 
(National Institute of Mental Health, 2009a) and is the third largest contributing factor to the 
global burden of disease (World Health Organization, 2003).  In addition to the toll on the 
quality of life, mental disorders produce immense financial strains associated with treatments, 
reduced productivity, increased incarceration, and increased mortality rates that not only the 
patient, but also society must endure (Surgeon General, 1999; World Health Organization, 2003).  
In the United States, there is an estimated $193 billion annual income deficit for all mental 
disorders (Kessler et al., 2008; National Institute of Mental Health, 2009b); $53 million is 
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estimated from depression alone (Greenburg, et al., 1996).  However, a more imperative issue is 
the significant population of patients that are unaffected by or experience serious side effects 
with the current therapeutic options (Davidson & Conner, 2004; Krishnan, 2004; Nelson, 2004; 
Rosenbaum & Tollefson, 2004), thus creating a need for more efficacious treatments with fewer 
side effect profiles.  Advancements in novel pharmacological therapies for anxiety and 
depression, as well as other psychiatric disorders, heavily rely on the development, validation 
and utilization of animal models.   
 According to Willner (1991a), there are three types of animal models which include 
screening assays, behavioral bioassays, and simulations. Screening assays evaluate and compare 
the drug action of novel compounds with known compounds to identify potential clinical uses 
(e.g., antidepressant or anxiolytic effects).  Since they are solely concerned with observing a 
positive or negative outcome analogous to clinical trials, screening assays must only adhere to 
predictive validity.  Predictive validity is the degree to which a model can accurately predict the 
performance of novel or known drug actions based on the outcome observed.  Behavioral 
bioassays examine the physiological functions underlying a particular behavior or disorder and 
it’s response to drug treatments. In addition to examining the mechanisms that alter brain 
functioning due to a disorder or treatment, behavioral bioassays are also able to identify novel 
physiological targets for drug development.  These models are subject to construct validity: the 
theoretical rationale upon which the model is founded and asks a variety of questions narrowing 
down to, “Does the model correctly measure the characteristics associated with the human 
disorder.”  Simulations are intended to mimic a disorder by assessing behaviors relative to a 
particular species and disorder to determine the etiology, physiological foundations, and 
responses to drug treatments.  For a simulation to correctly model a clinical disorder, it is to 
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adhere not only to predictive and construct validity, but also face validity.  Face validity 
evaluates the similarity between the model and the actual human disorder in terms of the 
etiology, physiology, symptomatology, and treatment effects. The simulation and the disorder 
should have as many similarities as possible and the face validity is subject to change as new 
information arises (Willner, 1991a).  In addition to being characterized by these three types of 
validity, animal models should also adhere to the principles of generalizability and 
reproducibility (Miczek & Wit, 2008; van der Staay, 2006).The utilization of sound animal 
models has led to significant advances in our knowledge and treatment of anxiety and depression 
(Willner, 1991a). 
Traditional animal models of anxiety induce anxiety-like symptoms using conflict and/or 
conditioned or unconditioned responses to threat.  Anxiety models also use exploratory 
paradigms such as the open field test, elevated plus maze, holeboard and light-dark box (for 
review see, Bourin, Petit-Demoulie`re, Dhonnchadha & Hascoäet 2007; Ladner, 1991).  Such 
tests are designed to measure avoidance, the latency period to perform the task, which is 
increased with stress-inducing stimuli or situations, and reduced after the administration of 
anxiolytic drugs (Green & Hodges, 1991). Most animal models of depression employ either 
stress (e.g., chronic mild stress), learned helplessness (e.g., forced swim test), or separation-
isolation paradigms to engender depressive-like characteristics in animals (for review see, 
Willner, 1991b).  Animal models of depression attempt to mirror the characteristics of the human 
disorder, to examine the drug-induced behavioral changes and the neurochemical effects 
(McArthur & Borsini, 2006).  Animal models help us to understand and treat anxiety and 
depression by identifying of the disorders’ multifaceted symptom profiles determining the 
etiological foundations which initiate the development of  more target specific drug treatments, 
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and facilitating research of the physiological responses to novel therapeutic drug treatments 
(Ladner, 1991).  However, despite these advances, many criticisms of animal models have been 
recently raised.  
Kalueff, Wheaton, and Murphy (2007) offer a number of criticisms of current rodent-
based models of anxiety and depression. First, animal models provide questionable within- and 
between-laboratory reliability owing to varying results.  A second criticism of animal models is 
the constraints of species-specific behaviors through artificial environments (e.g., exploratory 
paradigms); which often restrict the environment so any movements may be due solely to the 
environment, not necessarily innate behaviors (Whishaw, Gharbawie, Clark, & Lehmann, 2006).  
Other criticisms include an over emphasis on either internal genetic (e.g., strain differences) or 
external epigenetic (e.g., environmental) factors.  Lastly, these authors as well as Frazer & 
Morilak (2005) suggest that animal models should attempt to simulate the multi-syndromal 
aspect of anxiety and depressive disorders (Frazer & Morilak, 2005; Kalueff et al.,2007) due to 
the increasing amount of data showing high comorbidity rates between anxiety and depressive 
disorders (Gorman, 1996-1997; Kessler et al., 1994, 2005; Rivas-Vazquez et al., 2004). 
 Because the comorbid presentation rates of anxiety and depression are so prevalent 
(Gorman, 1996-1997; Kessler et al., 1994, 2005; Rivas-Vazquez et al., 2004), the two disorders 
are now suggested to be on a single continuum (Kasper, 2001).  The anxiety-depression 
continuum theory states that anxiety and depression are different temporal facets due to repeated 
stressors with anxiety-like symptoms preceding depression-like symptoms (Kasper, 2001). 
However, current animal models of anxiety and depression examine the two disorders separately, 
so as to mirror the classification by the Diagnostic and Statistical Manual of Mental Disorders-
IV (American Psychiatric Association, 1994). Owing to the recent data showing high 
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comorbidity rates, current animal models are not producing adequate information to treat anxiety 
and/or depression. To resolve this lack of sufficient animal models, Kalueff et al., (2008, 2007) 
suggest a “hybridization” of anxiety and depression models.   
 Sufka et al. (2006) proposed such a “hybrid” model to examine the anxiety-depression 
continuum theory by combining two paradigms that measured the same behavioral response, 
distress vocalizations, to a social isolation stressor in domestic fowl chicks (Lehr, 1989; 
Panksepp, Vilberg, Bean, Coy, & Kastin, 1978; Panksepp, Meeker, & Bean, 1980; Panksepp, 
2003). This “hybrid” model, the chick anxiety-depression continuum model, involves isolating 
chicks from conspecifics and measuring the distress vocalizations (DVocs) over a 2-hour test 
session which reveals both an anxiety-like phase and a depression-like phase within a single 
paradigm (Sufka et al., 2006).  Within the first 5-min of isolation, DVocs rates are relatively high 
which is indicative of an anxiety-like (panic-like) state whereby chicks attempt to reestablish 
social contact.  In the next 20-25 min of isolation, DVoc rates display a steady decline which is 
characterized as a transitional period.  In the final 30-120-min of isolation, DVocs reach a 
plateau of approximately 50% of the initial rate which is characteristic of a depression-like state 
(i.e., behavioral despair).  
In addition, the anxiety- and depression-like phases can be pharmacologically dissociated 
by administering diverse compounds possessing anxiolytic and antidepressant effects.  
Compounds with anxiolytic effects (e.g., chlordiazepoxide, clonidine, and imipramine) attenuate 
the high DVoc rates during the anxiety-like phase, whereas compounds with antidepressant 
effects (e.g., imipramine, maprotiline, and fluoxetine) attenuate the reduction in DVoc rates 
during the depression-like phase (Sufka et al., 2006; Warnick, Huang, Acevedo & Sufka, 2009). 
Further, common stress and depression biomarkers present within the model and include 
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elevated corticosterone and interleukin-6 (IL-6) levels (Sufka et al., 2006; Warnick et al., 2009). 
A recent study that efficacy screened 7 compounds targeting novel CNS sites, each of which 
previously passed antidepressant screening in rodent models, yielded a somewhat different 
profile than those early pre-clinical screens. The chick anxiety-depression model identified 
prasterone, ketamine, mifepristone, CGP36742 and DOV216,303 as possessing antidepressant 
properties while memantine and antalarmin did not (Sufka et al., 2009). Interestingly, this pattern 
of effects is in line with early clinical trial outcomes and illustrates the predictive validity of the 
model by correctly detecting efficacy of some compounds while avoiding two false positives 
(Wolkowitz et al., 1999; Zarate et al., 2006a; Zarate et al., 2006b; Belanoff et al., 2002; 
Schechter et al., 2005). Collectively, these results begin to provide support for the validity of the 
model as a neuropsychiatric simulation and screening assay. 
 Further enhancing the validity of the chick anxiety-depression model requires 
strengthening the amount of connections made between the model and the clinical presentation 
of anxiety and depression (Miczek & Wit, 2008; Panksepp, 2006; van der Staay, 2006;). An 
approach to this type of enhancement is through quantifying behavioral endophenotypes which 
are defined as “a set of behavioral and/or physiologic characteristics that accompany a basic 
process that is altered in relation to the illness that is being studied” (Bakshi & Kalin, 2002).  The 
use of endophenotypes must occur in a top-down fashion whereby the characteristics that make 
up the human clinical disorder are translated and understood within the natural behavior of the 
model species (i.e., domestic chicks) (van der Staay, 2006). Humans suffering from anxiety 
and/or depression have demonstrated the endophenotype of cognitive disturbances and being 
able to quantify similar kinds of cognitive disturbances in the chick anxiety-depression model 
can strengthen this paradigm as a neuropsychiatric simulation (Kalueff & Murphy, 2007).   
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Cognitive bias is a phenomenon that presents in individuals suffering from anxiety and/or 
depression in which cognitive disturbances elicit negative interpretations of ambiguous stimuli 
and/or events.  More specifically, anxiety is associated with increased negative expectations of 
future events, known as more pessimism, whereas depression is associated with both increased 
negative expectations and also decreased positive expectations of future events, known as less 
optimism (Wright & Bower 1992; MacLeod & Byrne 1996). Further, both anxious and 
depressed individuals make more negative interpretations of themselves (Beck, 1963 as cited in 
Clark & Beck, 1999), and negative interpretations of future (Butler & Mathews, 1983, 1987) 
and/or current events (Schwarz & Clore, 1983) for themselves and others (Alloy & Ahrens, 
1987).  In his cognitive model of psychopathology, Beck (1976) proposed that such cognitive 
disturbances are not only a product of, but may also play a role in maintaining anxiety and 
depression due to the constant processing of negative information and negative recurring 
thoughts. Therefore understanding the behavioral processes of such cognitive disturbances may 
help to reduce the severity of anxiety and/or depression.  
In a study that clearly showed the cognitive biases associated with anxiety and 
depression, Miranda & Mennin (2007) assessed participants’ predictions of future events.  
Participants completed a questionnaire which contained positive and negative future events for 
which they were to indicate “yes” or “no” the event would likely to occur to them and then how 
certain they were.  Both anxious and depressed individuals were more pessimistic in their beliefs 
about negative events occurring to them; however only depressed individuals were less 
optimistic in their beliefs of positive events occurring to them (Miranda & Mennin, 2007). These 
results are consistent with a study by MacLeod & Byrne (1996) in which anxious individuals 
showed an increase in expectations of negative events and depressed individuals showed both an 
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increase in expectations of negative events and decreased expectations of positive events for 
events occurring presently, in a week, or in 5-10 years. 
There have been several paradigms used to measure the effects of cognitive bias in 
anxious and depressed individuals including interference tasks, attentional probe tasks and 
homophone tasks (for review see, Mathews & MacLeod, 1994; Mogg & Bradley, 2005). The 
most common cognitive interference task is a modified version of the Stroop Task wherein the 
words presented in colored ink are either neutral or threat-related words (e.g., collapse, death, 
and failure), and the participant is to respond with the content of the word rather than the color. 
Anxious individuals displayed longer latencies for the color-naming of threat-related words as 
compared to neutral words; indicating that the threat-related words create a greater cognitive 
interference relative to the neutral words relative to than threat-related or neutral words 
(Matthews and Macloed, 1985). Whereas depressed individuals displayed greater latencies when 
color-naming negative self-descriptive or negative socially-related words relative to neutral 
words (Mogg & Bradley, 2005) (Mathews & MacLeod, 1994); they also displayed greater 
latencies when color-naming depressed-related words relative to neutral- or manic-related words 
(Gotlib & McCann, 1984). 
 To assess the performance of patients with concurrent generalized anxiety disorder 
(GAD) and depression, Bradley,  Mogg, Millar, & White (1995) used the Stroop Task with 
anxiety-related (e.g., disgrace, cancer), depression-related (e.g., misery, discouraged), 
categorized neutral (household terms, e.g., carpet, domestic) or uncategorized neutral (e.g., 
geometry, exchange) words in either supraliminal or subliminal conditions.  The results revealed 
that GAD participants without concurrent depression displayed longer color-naming latencies for 
the anxiety-related words relative to the neutral words, more so than the participants with GAD 
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and concurrent depression. In addition, the GAD participants without concurrent depression 
displayed longer color-naming latencies for anxiety- and depression-related words relative to 
neutral words in both supraliminal and subliminal conditions.  
To assess cognitive bias in the attention of anxious and depressed individuals, visual 
probe tasks are utilized.  In these tasks, word pairs, one negative and one neutral word, are 
presented on a computer screen and followed by a small dot probe presented in the area where 
either the negative or neutral word had appeared.  Anxious individuals displayed faster probe 
detection of dots presented in the negative word location as compared to the neutral word 
location, suggesting that anxious individuals allocate more attention to the negative stimuli 
whereas controls tended to shift attention from the negative probes.  In contrast, depressed 
individuals did not display differences in probe detection latencies presented in either the 
negative or neutral word location (MacLeod, Mathews, & Tata, 1986).  
Cognitive biases in anxiety and depression can also be observed using the homophone 
task wherein a previously recorded audio tape presents ambiguous homophones differing in 
spelling and emotional valance, either threat-related or neutral words (e.g., die/dye or guilt/gilt).  
Anxious individuals (Eysenck, MacLeod, & Mathews, 1987; Mathews, Richards, & Eysenck, 
1989) as well as depressed individuals (Mogg, Bradbury, & Bradley, 2006) reported a higher 
number of threat-related rather than neutral homophones when compared to non-anxious 
controls.  In addition, anxious individuals also displayed greater amounts of skin conductance 
responses to threat-related stimuli than to neutral-stimuli during the homophone task when 
compared to controls (Mathews et al., 1989). Similar studies have also found a negative 
interpretation bias in anxious individuals using a modification of the RSVP paradigm which 
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presents either ambiguous passages (MacLeod & Cohen, 1993) or ambiguous sentences 
(Eysenck, Mogg, May, Richards, & Mathews, 1991).  
Interestingly, cognitive bias is sensitive to a variety of therapies affecting mood 
disturbances.  For example, Cognitive Behavioral Therapy (CBT) has been shown to reverse the 
negative interpretation bias in patients treated for generalized anxiety disorder patients (without 
concurrent depression) (Mogg, Bradley, Millar, & White, 1995). Participants were tested twice, 
two months apart, using the modified Stroop task with anxiety-related (e.g., disgrace), 
depression-related (e.g., discourage) and neutral words (e.g., domestic) in masked, replaced with 
a letter string, and unmasked exposure conditions.  In first test session the anxiety participants 
displayed longer color-naming latencies for the negative words for both conditions relative to the 
control group.  In the second test session, after the anxiety patients received CBT, there were no 
differences in color-naming latencies for negative words between CBT treated anxious patients 
and the controls.  One additional study by Mathews, Mogg, Kentish, & Eysenck (1995) observed 
the effects of CBT on anxiety patients using the modified Stroop task, an attentional search task, 
and a word completion task.  Prior to treatment, the anxious participants displayed longer color-
naming latencies for threatening words and displayed longer latencies to locate targets among 
threatening distractors relative to non-threatening distractors when compared to controls. 
However, no differences were found between group, priming, and word valance on the word 
completion task, which is inconsistent with previous findings.  After CBT treatment, the negative 
interpretation bias for the anxious individuals was reduced and no longer significantly differed 
from the controls on the Stroop task and the attentional search task (Mathews et al., 1995). 
Cognitive behavioral therapy has also been used to reverse the cognitive bias observed in 
depressed individuals.  In a study by Segal & Gemar (1997) depressed patients were tested on a 
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primed modified Stroop Task before and after having received CBT.  The Stroop Task target 
words were primed by emotional phrases that varied in their degree of self-descriptiveness. The 
primes were presented in black and white before the to-be-named negative self-descriptive or 
negative non-self-descriptive word appeared.  Segal and Germar (1997) found that before CBT 
treatment, depressed patients displayed longest response latencies when both the prime and 
target word were negatively self-descriptive.  Following CBT treatment, patients that showed the 
most recovery also showed greater improvement for color-naming interference for the negative 
self-descriptive targets primed by the negative self-descriptive phrases when compared with the 
negative non-self-descriptive phrases.  The patients that still had high levels of depression 
following treatment showed higher levels of negative interference in the same prime/target 
condition, resembling the non-treated depressed patients (Segal & Germar, 1997).  Similar 
reversal patterns are observed for the cognitive bias in anxiety and depression using 
pharmacotherapies  
Using pharmacotherapy to reverse the cognitive bias seen in anxiety, Weinstein & Nutt 
(1995) reported that before treatment, anxious individuals displayed longer response latencies for 
emotional words on the modified Stroop task as compared to a recovered anxious, depressed and 
control group.  After treatment with SSRIs (serotonin selective reuptake inhibitors), 
antidepressants also known to have anxiolytic properties, the previously anxious patients no 
longer significantly differed from the control group; suggesting that cognitive bias is responsive 
to pharmacological treatments (Weinstein & Nutt, 1995).  In a similar study, Mogg, Baldwin, 
Brodrick, & Bradley (2004) observed a reversal of symptoms of cognitive bias in anxiety with 
SSRI treatment using the homophone task.  After administration of SSRIs, anxious individuals 
displayed not only lower levels of anxiety, but also lower levels of negative interpretive biasing 
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on the task.  Further, the cognitive bias processes decreased as a function of improvement in the 
treatment of anxiety; the more efficacious the treatment, the fewer negative interpretations 
presented (Mogg et al., 2004).  Though these findings seem promising, not all of the drug classes 
produced similar results.  
Golombok et al. (1991) was unable to observe a reversal of cognitive bias on the 
modified Stroop task upon administration of the benzodiazepine anxiolytics. Although the 
benzodiazepines did appear to reduce anxiety and create an overall slowing of latencies for the 
task, there were no improvements in the negative interpretation biases. Golombok et al. (1991) 
concluded that the benzodiazepines only ameliorate an anxious mood, not the cognitive 
disturbances associated with anxiety.  In a similar study, Stewart, Westra, Thompson, & Conrad 
(2000) wanted to observe the effects of naturalistic benzodiazepine use (i.e. taken on an “as 
needed basis”) on cognitive bias within a variety of anxiety disorders (e.g., generalized anxiety 
disorder, post traumatic stress disorder) to assess possible tolerance effects on the cognitive 
impairments produced by benzodiazepines and also to test the theory that benzodiazepines 
increase attention to threat-related stimuli. Consistent with the results from Golombok et al. 
(1991), individuals currently taking benzodiazepines did not reveal any improvements in the 
negative interpretation bias as compared to the medication nonusers.  Further, the 
benzodiazepine users displayed greater attention to threat cues than the medication nonusers 
suggesting that the benzodiazepines do increase attention to threat-related stimuli (Stewart et al., 
2000).   
A study by Harmer, O’Sullivan, Favaron, Massey-Chase, Ayres, and Reinecke et al. 
(2009) examined the effects of a single dose of reboxetine, a norepinephrine selective reuptake 
inhibitor, or a placebo on negative affective bias in depressed individuals and healthy controls.  
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Three hours after drug administration all participants were tested using a facial expression 
recognition task and an emotional categorization and memory task. The administration of 
reboxetine did not produce changes in mood or anxiety in either patients or controls.  The facial 
expression recognition task which required individuals to identify the correct emotional 
expression (e.g., happiness, surprise, sadness, fear, and anger) revealed that depressed 
individuals were less accurate in recognizing facial expressions of happiness and surprise 
compared to the controls, indicative of cognitive bias. This effect was reversed by reboxetine 
which increased the perception of happy facial expressions in depressed individuals. In a 
separate task, depressed individuals displayed longer response latencies for positive self-
referential characteristics relative to negative self-referential characteristics compared to 
controls, indicative of a negative bias when judging one’s personality.  This effect was reversed 
by reboxetine which shortened response latencies for positive self-referential characteristics in 
depressed individuals.  Further, depressed individuals had the worst recall of personality 
characteristics, especially those that were positive on the emotional memory task. This effect was 
reversed by reboxetine which improved recall of the positive self-referential characteristics 
(Harmer et al., 2009).  
 It is interesting to note that the phenomenon of cognitive bias in humans has also been 
examined in non-human animals such as rhesus macaques, dogs, rats, and avians subjected to 
various stressors (Bateson & Matheson, 2007 Bethell, Semple, Holmes, & MacLarnon, 2007; 
Brilot, Normandale, Parkin, & Bateson, 2009; Burman, Parker, Paul, & Mendl, 2009; Harding, 
Paul, & Mendl, 2004; Matheson, Asher, & Bateson, 2008; for review see Mendl, Burman, 
Parker, & Paul, 2004). For example, Bateson & Matheson (2007), trained European Starlings on 
a go/no-go task to differentiate between two visual stimuli, colored cardboard lids, representing 
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appetitive or aversive outcomes (e.g., white lids concealed a palatable mealworm; black lids 
concealed an aversive tasting mealworm). Prior to testing, the housing conditions were 
manipulated from an enriched to an impoverished environment, (inducing a more pessimistic 
state) or from an impoverished to an enriched environment (inducing a less optimistic state).  At 
testing, starlings were exposed to ambiguous colored lids, intermediate shades of grey between 
black and white.  Starlings that were switched from an enriched to an impoverished environment 
were less likely to flip the intermediate grey lids than those that were switched from an 
impoverished to an enriched environment (i.e., more pessimistic behavior after a decline in 
environment).   Matheson et al., 2008, utilized a similar paradigm to assess the effects of chronic 
enriched or standard housing environments on cognitive bias.  In this study, starlings were 
trained to differentiate two temporal stimuli (e.g., 2 versus 10 second light stimuli) for an instant 
or delayed food reward and at test were exposed to a range of ambiguous temporal durations 
within the 2 to 10 second range.  Compared to starlings housed in an enriched environment that 
were more likely to classify the ambiguous stimuli as being associated with an instant food 
reward, those in standard housing were less likely to do so.  The behavior of starlings housed in 
standard cages reflects less optimism associated with depression-like states.  
 More recent studies of cognitive bias have examined behavioral responses to 
ecologically-relevant stimuli that are likely to produce similar approach-avoidant responses, but 
without extensive training.  Brilot et al., 2009, used variations of eyespots, which are naturally 
aversive to many avian species, in conjunction with neutral or threatening, anxiety producing, 
calls to assess cognitive biases in starlings. Immediately after playing a particular call they 
recorded the starlings’ behavior in front of either eyespots, ambiguous eyespots, or no eyespots. 
Although there was no interaction between the anxiety states induced by different calls and 
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responses to the various eyespot stimuli, the eyespots did reveal to be generally aversive to 
starlings and therefore an accurate assessment of anxiety and approach behavior.  
 To measure approach-avoidant behaviors in domestic fowl chicks, Salmeto et al. (in 
preparation) used a straight-alley maze, a paradigm used to quantify chick social reinstatement 
(Marin, Freytes,, Guzman, & Jones, 2001) with start and goal latencies as the dependent 
measure. Various stimulus cues were located at the goal which served as the approach-avoidant 
manipulation. The stimulus cues were a silhouette of a conspecific chick (or mirror), a silhouette 
of a horned owl, a natural predator to the chick, and three intermediate ambiguous silhouettes 
with varying degrees of characteristics between the two (e.g., 75c:25o, 50c:50o, 25c:75o).  In 
Experiment 1, non-stressed chicks displayed start latencies that were unaffected by the various 
stimulus cues, whereas goal latencies were longer under cues with greater owl silhouette 
characteristics.  
 These results reveal that the range of stimulus cues produce the necessary 
approach/avoidant behavior to examine cognitive bias under anxiety- and depressive-like states. 
One interesting finding was that chicks displayed longer goal latencies under the Chick stimulus 
cue than for the mirror cue in the pre-test session.  Therefore, the second experiment replaced the 
Chick stimulus for the mirror to promote more life-like characteristics than that of a still image to 
allow for the most effect approach behavior.  
 Experiment 2 utilized the same procedure with the introduction of an initial isolation 
manipulation to induce either an anxiety-like state (5-min isolation) or a depression-like state 
(60-min isolation).  In the social condition, start latencies were unaffected by the various 
stimulus cues, which is consistent with Experiment 1 results.  In the anxiety-like condition, start 
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latencies were significantly longer under the stimulus cues with greater aversive characteristics 
(e.g., 50c:50o, 25c:75o, and Owl) relative to the social condition.  These results reflect the 
cognitive bias of more pessimism, which is an increased avoidant behavior to ambiguous 
aversive stimuli. In the depression-like condition, start latencies were significantly longer under 
the stimuli with greater aversive characteristics, as well as greater appetitive characteristics (e.g., 
Chick and 75c:25o) relative to the social condition.  These results reflect the cognitive bias of 
more pessimism, as well as less optimism, which is a decreased approach behavior to ambiguous 
appetitive stimuli. 
  However, the goal latencies did not produce such clear results. Relative to the social 
condition, goal latencies in the anxiety-like and depression-like conditions were significantly 
longer under the 50c:50o and the Owl stimulus cues (i.e., more pessimism), but not the 25c:75o 
stimulus cue.  In addition, goal latencies in the depression-like conditions were significantly 
longer in the Chick cue (i.e., less optimism), but not in the 75c:25o stimulus cue. These results 
may be due to a ceiling effect imposed by the 5-min test session criteria as many of the chicks 
did approach the cues to varying degrees but did not reach the goal line.  
  Collectively, these observations reveal that a runway test to ambiguous appetitive and 
aversive cues can assess both types of cognitive biases within a single paradigm. In addition, the 
chick model produced results that are consistent with how cognitive bias presents in the human 
clinical literature, wherein more pessimism is present in the anxiety-like state and both more 
pessimism and less optimism are present in the depression-like state. 
 Animal models are evaluated on their validity and one way to strengthen validity is to 
increase the number of homologies between the human clinical disorder and the model. Given 
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that the chick anxiety-depression continuum model is able to show cognitive bias and given that 
humans show a reversal of cognitive bias subsequent to treatment, it should follow that cognitive 
bias can be reversed in the chick model. Therefore this research will attempt to reverse these 
forms of cognitive biases in the two clinical states modeled by the chick anxiety-depression 
continuum simulation with pharmacological probes.  These findings would provide a further 
validation of the chick anxiety-depression continuum model as a neuropsychiatric simulation.   
Methods 
Subjects and Housing Characteristics 
 Cockerels (Gallus gallus; W36; Cal-Maine Foods, Inc., Mendenhall, Mississippi, USA) 
were received 1-day post hatch and housed in 34 × 57 × 40 cm stainless steel cages with 12–13 
chicks per cage. Chicks were removed and briefly handled daily to minimize experimenter-
related stress. Food (Purina Start and Grow, St Louis, Missouri, USA) and water was available 
ad libitum through one quart gravity-fed feeders (Murray MacMurray; Model 4BGFJ) and 
waterers (Murray MacMurray; Model 4YQW0).  Room temperature was maintained at 29 ± 1 °C 
and overhead illumination was maintained on a 12-h light-dark cycle. 
Apparatus 
Straight alley maze 
 The apparatus consisted of a 50 x 30 x 10 cm arena made of opaque high-density 
polyethylene material that contained a straight alley maze adjacent to a holding arena (see Fig. 
1).  The straight alley maze consisted of a 10 x 10 x 10 cm start box with a guillotine door that 
opens up to a 40 x 10 x 10 cm runway with either an 8 x 10 cm mirror or various 8 x 10 cm 
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stimulus cues placed at its end (detailed below). The runway contained markings in 5 cm units 
that permitted a measure of distance traveled.  A 40 x 20 x 10 cm holding arena housed 12 
conspecifics throughout the test session and permitted the testing of chicks under non-isolated 
treatment conditions.  These conspecifics remained out of view during maze testing.  However, 
once chicks reach the goal, full view of the arena was permitted through a 20 x 10 cm clear 
Plexiglas wall. Pine bedding was placed throughout the arena floor and food and water was 
available ad libitum in 200 ml stainless steel cups.  A pilot study demonstrated that 
approximately 90% of non-isolated chicks exited the start box within 30 sec and reached the goal 
within 60 sec of a 5 min test period under the mirror test condition. 
Morphed Stimulus Conditions 
 Morpheus Photo Morpher v3.01 Professional for Mac (Morpheus Software, LLC) was 
used to produce ‘morphed’ images that blended elements of a chick and a horned owl silhouette. 
To determine whether the owl silhouette served as an aversive cue, a second pilot study was 
conducted using two test sessions separated by one day.  The first test was conducted using the 
mirror cue and replicated the findings of the first pilot study.  The second test utilized the owl 
silhouette cue and demonstrated that approximately 85% of non-isolated chicks exited the start 
box within 30 sec and approximately 80% failed to reach the goal within the 5 min test period.  
 From the chick and owl silhouette cues, software mapped a series of approximately 200 
dots onto each photos to match the location of the dots between the images. This allowed for 100 
morphed frames linking the start (chick) and end (owl) photos. Within this series two key frames 
were defined: 75% chick and 25% owl, and 25% chick and 75% owl were used (75c:25o and 
25c:75o). The pixellated edges of the images were smoothed out and the images were adjusted so 
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that they were all approximately the same size and fit on an 8 x 10 cm stimulus card. The images 
were saved as jpeg files, printed and placed behind a clear glass plate during testing (see Fig. 2). 
Isolation Apparatus  
 A six-unit test apparatus containing Plexiglas viewing chambers (25x 25x 22 cm) situated 
in sound-attenuating enclosures was used for behavioral data collection. The units were 
illuminated using 25W light bulbs and ventilated by an 8-cm diameter rotary fan (Model FP- 
108AXS1; Rodale, Great River, New York, USA). Miniature video cameras (Model PC60XP; 
SuperCircuit, Liberty Hill, Texas, USA) mounted at floor level in the corner of the enclosures 
and routed through a multiplexer (Model PC47MC; SuperCircuit) allowed for animal 
observation. Distress vocalizations were collected via microphones [Model 3-675-001 
(modified); Lafayette Instruments, Lafayette, Indiana, USA] mounted on the rear wall of the 
Plexiglas chamber, routed through sound-activating relays (Model 630400A; Lafayette 
Instruments; settings: 60–75% sensitivity, 0.10-s delay) and collected a USB interface via 
custom-designed software 
Experiment 1 
 Procedure  
 Experiment 1 was conducted to ensure that drug treatments, clonidine and imipramine, do 
not substantially influence cognitive decision making to natural and ambiguous appetitive and 
aversive stimulus cues in the social treatment condition.  In this experiment, chicks were tested 
across ages 4-6 days post hatch. In the first trial, at age 4 days post hatch, 12 cagemate 
conspecifics were placed into the holding arena and individually tested in the maze under the 
mirror cue condition. Each chick was placed into the start box for 15 sec after which the 
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guillotine door was raised.  Dependent measures were start and goal latencies and farthest 
distance traveled. Start latency was defined as the time it takes to step completely outside the 
start box. Goal latency was defined as the time to cross a defined mark located 10 cm away from 
the mirror or stimulus cue. Because all test sessions were terminated at 5 min, the farthest 
distance traveled (cm) from the start box was measured to account for possible differences 
between chicks that complete the straight alley maze and those that did not. Chicks were placed 
back into the holding arena until all were tested.  Group assignment for Trial 2 was based on goal 
latencies from this test session. 
 The second trial was conducted at either 5 or 6 days post hatch and consisted of three 
social groups that were administered either 0.15mg/kg clonidine (tested for 5-min), 15mg/kg 
Imipramine (tested for 60-min), or a physiological saline (tested for 60-min). All chicks were 
injected with drug probes 15-min prior to apparatus testing and were tested with two cagemate 
conspecifics.  Following apparatus testing, chicks were transported from the isolation apparatus 
in a 2 quart opaque plastic container and tested immediately in the maze under four stimulus cue 
conditions: mirror, 25c:75o morph, 75c:25o morph: and 0c:100o (owl silhouette), based on the 
goal latencies from Trial 1. To assess a baseline for each stimulus cue, a no-isolation test control 
group was administered saline and tested immediately within the maze. In addition, these chicks 
remained in the arena throughout the test session. Dependent measures for the maze are as 
described above. Chicks were returned to their home cage after testing.  
Statistical Analysis 
 To assess for significant isolation-group differences and significant pharmacological 
effects on distress vocalizations in the anxiety-like and depression-like phases, all DVocs were 
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transformed into a rate/min function.  A 1-way ANOVA was conducted on the anxiety-like 
phase (i.e., first 5-min/5) and on the depression-like phase (i.e., 30-60min/30).  Post-hoc analyses 
were conducted using Fisher’s least significant difference tests. 
 To assess for significant isolation-group differences and significant pharmacological 
effects on the cognitive biases seen under each individual stimulus cue, four 3 x 5 MANOVAs 
were conducted with mean start latency, mean goal latency, and mean distance traveled as the 
dependent variables.  A priori planning to assess group differences across each stimulus cue 
individually set the MANOVA p-value at p > 0.0125. Given the significance of the MANOVA, a 
1-way ANOVA was conducted upon each dependent variable. Given the significance of the 
ANOVA, a Tukey’s Post Hoc analysis was conducted to compare group means of the five drug 
treatment conditions.  Chicks that were clearly sedated within the maze were discarded from the 
analysis. Sedation was operationally defined as either falling asleep or appearing drowsy with 
eyes closing.  
Results 
Distress Vocalizations  
 The effects of various drug treatments on DVocs rates for chicks tested socially (i.e., with 
two cagemate conspecifics) in the anxiety-like and depression-like phases are presented in Figure 
3, respectively. Chicks in the vehicle group (tested for 60-min) displayed relatively high DVoc 
rates in the first 5-min, indicative of an anxiety-like (panic-like) state; then, DVoc rates declined 
by approximately 50% of the initial response rate during the final 30-min of the test session (i.e., 
30-60 min), indicative of a depression-like state (i.e., behavioral despair).  Chicks in both the 
anxiety-clonidine and depression-imipramine groups displayed DVoc rates that were 
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significantly attenuated compared to the vehicle group in the anxiety-like phase.  In addition, 
chicks in the depression-imipramine group displayed DVoc rates that were significantly higher 
compared to the vehicle group in the depression-like phase (i.e., 30-60 min) of isolation. 
 Consistent with these observations, a one-way ANOVA revealed a significant main effect 
for Treatment [F(2,95) = 12.46, p < 0.001].  Fisher’s PLSD post hoc analyses revealed that the 
anxiety-clonidine and the depression- imipramine groups displayed significantly lower mean 
DVoc rates compared to the vehicle group in the anxiety-like phase (ps < 0.001). In addition, the 
depression-imipramine group displayed significantly higher mean DVoc rates in the depression-
like phase (p < 0.001).  
Mirror Stimulus Cue    
 The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the mirror stimulus cue are presented in Figure 4 panels A, B, and 
C, respectively.  In the vehicle no-test group, mean start latency was relatively short (e.g., chicks 
left the start box in approximately 40-sec), and goal latency was relatively long (e.g., chicks 
reached the goal in approximately 2 ½-min; half the allotted time).  Mean distance traveled for 
the vehicle no-test group was approximately 27 cm, indicating that most chicks either completed 
the maze or approached the stimulus cue.  Mean start and goal latencies and mean distance 
traveled for the vehicle isolation-test group did not differ compared to the vehicle no-test group 
(ps = n.s.).  Mean start latency for the anxiety-clonidine group was somewhat shorter compared 
to the vehicle isolation-test group; however, mean goal latency and mean distance traveled for 
these groups were not.  Mean start and goal latencies and mean distance traveled for the 
depression-imipramine group did not differ from the two vehicle conditions (ps = n.s.).  
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 Consistent with these observations, a one-way MANOVA failed to reveal a significant 
multivariate main effect for treatment, Wilks’ λ = 0.531, F(9,75.60) = 2.49, p = 0.015, where p < 
0.0125 is considered significant, partial eta squared = 0.190. Power to detect the effect was 
0.808.  Given the absence of a significant MANOVA, no further analyses were conducted on 
these data. 
75c:25o (Ambiguous Chick Stimulus Cue) 
 The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of 
Figure 5, respectively.  In the vehicle no-test group, mean start latency was relatively short (e.g., 
chicks left the start box approximately under a minute), and goal latency was relatively long 
(e.g., chicks reached the goal in approximately 3 ½-min; more than half of the allotted time).  
Mean distance traveled for the vehicle no-test group was approximately 23 cm, indicating that 
most chicks either completed the maze or approached the stimulus cue.  In general, mean goal 
latency and mean distance traveled were unaffected by the various treatment conditions (ps = 
n.s.), see panels B and C of Figure 5.  However, mean start latency for the vehicle isolation-test 
group was longer compared to the vehicle no-test group and this effect was reversed by the 
depression-imipramine group and appeared to be reversed by the anxiety-clonidine group.  
 Consistent with these observations, a one-way MANOVA approached a significant 
multivariate main effect for treatment, Wilks’ λ = 0.480, F(9, 65.86) = 2.58, p < 0.013 where p < 
0.0125 is considered significant, partial eta squared = 0.217. Power to detect the effect was 
0.815.  Given the marginal significance of the overall test, the univariate main effects were 
examined.  Significant univariate main effects for treatment were obtained for mean start latency 
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F(3,29) = 5.62, p < 0.005. Tukey’s HSD post hoc comparisons revealed significantly longer 
mean start latency for the vehicle isolation-test group compared to the vehicle no-test group (p < 
0.01).  And, the depression-imipramine group revealed a mean start latency that was significantly 
shorter compared to the vehicle isolation-test group (p < 0.01) whereas, the anxiety-clonidine 
group was marginally significantly shorter compared to the vehicle isolation-test group (p = 
0.055).  
25c:75o (Ambiguous Owl Stimulus Cue) 
 The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of 
Figure 6, respectively.  In the vehicle no-test group, mean start latency was very short (e.g., 
chicks left the start box approximately under 10-sec), and goal latency was relatively long (e.g., 
chicks reached the goal in approximately 4-min; approaching cut off criteria).  Mean distance 
traveled for the vehicle no-test group was approximately 23 cm, indicating that most chicks 
either completed the maze or approached the stimulus cue.  Mean start latency for the vehicle 
isolation-test group was longer compared to the vehicle no-test and this effect was reversed by 
the depression-imipramine group and the anxiety-clonidine group.  In general, mean goal 
latencies were unaffected by the various treatment conditions (ps = n.s.), see panel B Figure 6.  
Mean distance traveled for the vehicle isolation-test group was shorter compared to the vehicle 
no-test group and this effect was reversed by the depression-imipramine group.   
 Consistent with these observations, a one-way MANOVA revealed a significant 
multivariate main effect for treatment, Wilks’ λ = 0.400, F(9, 70.73) = 3.59, p < 0.001, where p < 
0.0125 is considered significant, partial eta squared = 0.263. Power to detect the effect was 
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0.938.  Given the significance of the overall test, the univariate main effects were examined.  
Significant univariate main effects for treatment were obtained for mean start latency F(3,31) = 
13.67, p < 0.001, and for mean distance traveled F(3,31) = 5.97, p < 0.005. Tukey’s HSD post 
hoc comparisons revealed significantly longer mean start latency for the vehicle isolation-test 
group compared to the vehicle no-test group (p < 0.001).  The depression-imipramine and 
anxiety-clonidine groups revealed a mean start latency that was significantly shorter compared to 
the vehicle isolation-test group (ps < 0.01).  Further, mean distance traveled for the vehicle 
isolation-test group was significantly shorter compared to the vehicle-test group and the 
depression-imipramine group was significantly longer compared to the vehicle isolation-test 
group (ps < 0.01).  
0c:100o (Owl Stimulus Cue)  
The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the 0c:100o stimulus cue are presented in panels A, B, and C of 
Figure 7, respectively.  In the vehicle no-test group, mean start latencies were relatively short 
(e.g., chicks left the start box in under a minute); whereas, mean goal latencies were relatively 
long (e.g., chicks reached the goal in approximately 5-min; the cutoff criterion).   Mean distance 
traveled for the vehicle no-test group was approximately 20 cm, indicating that although most 
chicks approached the stimulus cue, they did not reach the goal.   Mean start and goal latencies 
and mean distance traveled for the vehicle-test, the anxiety-clonidine, and the depression-
imipramine were not significantly different compared to the vehicle no-test group.   
 Consistent with these observations, a one-way MANOVA failed to reveal a significant 
multivariate main effect for treatment, Wilks’ λ = 0.807, F(9,65.86) = 0.68, p < 0.73, where p < 
26 
 
0.0125 is considered significant partial eta squared = 0.069. Power to detect the effect was 0.244.  
No further analyses were conducted on these data. 
Discussion 
 Experiment 1 was conducted to determine if the drug probes, clonidine and imipramine, 
would have an effect on runway performance independent of a stress manipulation.  In previous 
experiments, chicks tested socially (i.e., with two cagemate conspecifics) exhibited a low rate of 
DVocs during a 60-min test session; that rate of DVocs was significantly increased compared to 
the socially tested condition when the chicks were tested in isolation (Sufka et al., 2006). Given 
these findings, we believed the test apparatus would not induce a significant amount of stress to 
socially tested chicks.  Therefore, three social groups administered clonidine, imipramine, or a 
vehicle which consisted of a physiological saline, were tested within the isolation apparatus 
which was immediately followed with maze testing.  Since all treatment groups should have 
performed similarly, a vehicle no-isolation test control was included to gather baseline runway 
data for each stimulus cue. Distress vocalizations served as the dependent behavioral measure. 
And, start and goal latency and distance traveled served as the dependent measures for the maze.  
Several unexpected finding arose and are discussed below. 
Distress Vocalizations 
 Although it was not predicted, the patterns of DVocs observed in the anxiety-like and 
depression-like phases were consistent with previous findings (Sufka et. al., 2006).  A significant 
difference in DVocs rates presented between drug-treatment groups within socially tested chicks.  
In the anxiety-like phase, DVocs for the clonidine and imipramine groups were significantly 
attenuated compared to the vehicle group.  And, in the depression-like phase, DVocs for the 
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imipramine group were significantly higher compared to the vehicle group.  Because differences 
exist in DVoc rates between drug groups for socially treated chicks, it appears that the chicks are 
experiencing some measurable amount of stress even within the social isolation manipulation.   
 Several factors could have collectively produced the stress experienced by the chicks, 
some of which include: experimenter stress, the injection procedure, novelty to the testing 
apparatus (Feltenstein, Ford, Freeman, & Sufka, 2002), and flock reduction. Chicks are housed 
12 to a cage and any amount of flock reduction may have facilitated the observed stress which 
was also attenuated with the drug probes administered.  Testing drug probes in socially tested 
chicks has not been examined. This is an avenue of research that should be further explored to 
gain a better understanding of the level of stress induced upon the chicks and prevented by the 
drug probes administered.  
Straight Alley Maze 
 Under the mirror and 0c:100o (owl) stimulus cues no observable behavioral differences 
existed in runway performance between the drug treatment groups; however, significant runway 
differences did present under the ambiguous stimulus cues.  Under the75c:25o (ambiguous chick 
cue), significant runway differences did present under mean start latency.  The vehicle isolation-
test group presented significantly longer mean start latencies compared to the vehicle no-test 
group.  Although this finding was unexpected, it agrees with the DVoc patterns observed for the 
vehicle isolation group (tested for 60-min), which are similar to the stress responses exhibited by 
isolated chicks, although to a lesser degree. Therefore, it follows that the difference between 
vehicle groups was due to the vehicle isolation-test group exhibiting less optimistic behavior 
(i.e., less approach behavior towards ambiguous appetitive cues) under a depressive-like state.  
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In addition, the less optimism observed under the depression-like state was reversed by 
imipramine in the depression-imipramine group which is also consistent with the significant 
reversal of DVoc rates in the depression-like phase.   
 A similar pattern was revealed under the 25c:75o (ambiguous owl cue) for mean start 
latency and mean distance traveled.  The vehicle isolation-test group presented significantly 
longer mean start latencies compared to the vehicle no-test group.  Again, this finding was 
unexpected, but it agrees with the DVoc patterns observed for the vehicle isolation group (tested 
for 60-min), which are similar to the stress responses exhibited by isolated chicks, although to a 
lesser degree. Therefore, it follows that the difference between vehicle groups was due to the 
vehicle isolation-test group exhibiting more pessimistic behavior (i.e., less approach behavior 
towards ambiguous aversive cues) under a depressive-like state.  In addition, the more pessimism 
observed under the depression-like state was reversed by imipramine in the depression-
imipramine group which is also consistent with the significant reversal of DVoc rates in the 
depression-like phase.  The vehicle isolation-test group also presented significantly shorter mean 
distance traveled compared to the vehicle no-test group.  This finding was unexpected given it 
was a novel measure, but it agrees with the both the DVoc patterns observed for the vehicle 
isolation group (tested for 60-min) and the cognitive bias of more pessimism observed. 
Therefore, it follows that the difference in mean distance traveled between vehicle groups was 
due to the vehicle no-test group exhibiting more pessimistic behavior (i.e., less approach 
behavior towards ambiguous aversive cues) under a depressive-like state.  In addition, the more 
pessimism observed under the depression-like state was reversed by imipramine in the 
depression-imipramine group which is indicated by a longer mean distance traveled. This finding 
is also consistent with the significant reversal of DVoc rates in the depression-like phase and the 
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significant reversal of the cognitive bias of more pessimism under an ambiguous aversive cue.  
Given the unexpected finding of differences within the vehicle groups, the vehicle no-test group 
was chosen to be the main control group for Experiment 2.  
 One additional finding was that for the anxiety-clonidine group, start latencies under the 
mirror, 75c:25o, and 25c:75o stimulus cues were significantly shorter compared to the vehicle 
isolation-test group and mean distance traveled under the 25c:75o stimulus cue was significantly 
shorter compared to the vehicle isolation-test group.  However we did not include a vehicle-5-
min test condition, because such differences were not expected.  Therefore, a fifth treatment 
group was added to the experiment; a vehicle 5-min isolation group to use as a control for the 
anxiety-clonidine group.  However, an alternative explanation for these observed effects could be 
that clonidine at a dose of 0.15mg/kg produced observable sedative effects within the runway. 
Chicks that were either sleeping or appeared drowsy within the maze were discarded from the 
analysis.   We believe that the sedative effects observed could be from clonidine acting in a 
context dependent manner.  More specifically, when given clonidine in a stressful environment it 
will act as an anxiolytic, but given in a minimally stressful environment it may produce sedative 
effects.  Clonidine’s behavioral effects beyond a 5-min isolation period or within a different 
testing apparatus have not been examined in this paradigm.  Therefore, we decreased the dose of 
clonidine given in Experiment 2 to 0.10mg/kg to lessen the likelihood of sedation.  
Experiment 2 
Procedure  
  Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a 
depression-like phase and to test whether those cognitive biases could be pharmacologically 
reversed.  More specifically, testing whether clonidine, an anxiolytic, could reverse the cognitive 
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bias of more pessimism (i.e., less approach behavior towards ambiguous aversive cues) observed 
under the anxiety-like phase.  And also, testing whether imipramine, an antidepressant with 
anxiolytic effects, could reverse not only the cognitive bias of more pessimism (i.e., less 
approach behavior towards ambiguous aversive cues) observed under the anxiety-like phase, but 
also the cognitive bias of less optimism (i.e., less approach behavior towards ambiguous 
appetitive cues) observed under the depression-like phase.  Experiment 2 was conducted 
following the same procedures as Experiment 1 with three exceptions: 1) a new treatment 
condition, a vehicle 5-min isolation group to use as a control for the anxiety-clonidine group; 2) 
lowering the dose of clonidine from 0.15mg/kg to 0.10mg/kg to lessen the likelihood of sedation 
within the runway; and 3) the induction of the isolation produce within the testing apparatus.  All 
dependent measures and statistical analyses remained the same.  
Results 
Distress Vocalizations 
 The effects of various drug treatments on DVocs rates for chicks tested in the anxiety-like 
and depression-like phases are presented in Figure 8, respectively. Chicks in the vehicle group 
displayed relatively high DVoc rates in the first 5-min, indicative of an anxiety-like (panic-like) 
state; then, DVoc rates declined by approximately 50% of the initial response rate during the 
final 30-min of the test session (i.e., 30-60 min); indicative of a depression-like state (i.e., 
behavioral despair).  Chicks in both the anxiety-clonidine and depression-imipramine groups 
displayed DVoc rates that were attenuated compared to the vehicle group in the anxiety-like 
phase (i.e., first 5-min) of isolation.  In addition, chicks in the depression-imipramine group 
displayed DVoc rates that were higher compared to the vehicle group in the depression-like 
phase (i.e., 30-60 min) of isolation.  
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 Consistent with these observations, a one-way ANOVA conducted on the anxiety-like 
phase revealed a significant main effect for Treatment [F(2,195) =42.43, p = 0.001]. Fisher’s 
LSD post hoc analyses revealed that the anxiety-clonidine and depression-imipramine groups 
displayed significantly lower DVoc rates compared to the vehicle group in the anxiety-like phase 
(ps = 0.001).  A one-way ANOVA conducted on the depression-like phase revealed a significant 
main effect for Treatment [F(1,100)=18.30, p = 0.001]. Fisher’s LSD post hoc analyses revealed 
that the depression-imipramine group displayed significantly higher DVoc rates compared to the 
vehicle group in the depression-like phase (p= 0.001) 
Mirror Stimulus Cue    
 The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the mirror stimulus cue are presented in panels A, B and C of 
Figure 9, respectively.  In the vehicle no-test group, mean start and goal latencies were relatively 
short (e.g., chicks left the start box in approximately 10-sec and reached the goal in under 40-
sec).  Mean distance traveled for the vehicle no-test group was 30 cm, indicating the runway was 
completed.  Mean start and goal latencies and mean distance traveled for the vehicle-anxiety and 
anxiety-clonidine groups did not differ from the vehicle no-test group or compared to each other  
(ps = n.s.).  
 Mean start latency for the vehicle-depression group was longer compared to the vehicle 
no-test group and this effect was reversed by the depression-imipramine group.  Mean goal 
latency for the vehicle-depression group was longer compared to the vehicle no-test group, and 
this effect was somewhat reversed by the depression-imipramine group.  Mean distance traveled 
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for the vehicle-depression group was somewhat shorter compared to the vehicle no-test group 
and this effect was somewhat reversed by the depression-imipramine group. 
 Consistent with these observations, a one-way MANOVA revealed a significant 
multivariate main effect for treatment, Wilks’ λ = 0.540, F(12, 156.39) = 3.42, p < 0.001, where 
p < 0.0125 is considered significant, partial eta squared = 0.186. Power to detect the effect was 
0.988. Given the significance of the overall test, the univariate main effects were examined.  
Significant univariate main effects for treatment were obtained for mean start latency F(4,61) = 
7.91, p < 0.001; mean goal latency F(4,61) = 6.37, p < 0.001; and, mean distance traveled, 
F(4,61) = 2.860, p < 0.05.   
  Tukey’s HSD post hoc comparisons revealed significantly longer mean start latency for 
the vehicle-depression group compared to the vehicle no-test group and a shorter mean start 
latency for the depression-imipramine group compared to the vehicle-depression group (ps < 
0.005).  Mean goal latency for the vehicle-depression group was significantly longer compared 
to the vehicle no-test group (p <0.001), and the depression-imipramine group revealed a 
marginally shorter mean goal latency compared to the vehicle-depression group (p = .065).  
Mean distance traveled for the vehicle-depression group was marginally shorter compared to the 
vehicle no-test group (p = 0.73), and the depression-imipramine group revealed a marginally 
shorter mean distance traveled compared to the vehicle-depression group (p = .083) 
75c:25o (Ambiguous Chick Stimulus Cue) 
 The effects of various drug treatment conditions on mean start and goal latencies and 
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of 
Figure 10, respectively.  In the vehicle no-test group, mean start latencies were relatively short 
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(e.g., chicks left the start box in under a minute); whereas, mean goal latencies were relatively 
long (e.g., chicks reached the goal in approximately 4-min).   The mean distance traveled for the 
vehicle no-test group was 25 cm, indicating that most chicks either completed the maze or 
approached the stimulus cue.  Mean start and goal latencies and mean distance traveled for the 
vehicle-anxiety group did not differ from the vehicle no-test group or from the anxiety-clonidine 
group (ps = n.s.). Mean start latency for the anxiety-clonidine group was somewhat longer 
compared to the vehicle no-test group, however mean goal latency and mean distance traveled 
did not differ from the vehicle no-test group (ps = n.s.).  
 Mean start latency for the vehicle-depression group was longer compared to the vehicle 
no-test group and this effect was reversed by the depression-imipramine group.   Mean goal 
latency for the vehicle-depression group did not differ from the vehicle no-test group and mean 
goal latency for the depression-imipramine group did not differ from the vehicle-depression 
group (ps = n.s).  Mean distance traveled for the vehicle-depression group was shorter than the 
vehicle no-test group and this effect was reversed by the depression-imipramine group.  
 Consistent with these observations, a one-way MANOVA revealed a significant 
multivariate main effect for treatment, Wilks’ λ = 0.592, F(12,145.81) = 2.66, p < 0.005, where p 
< 0.0125 is considered significant, partial eta squared = 0.160. Power to detect the effect was 
0.951. Given the significance of the overall test, the univariate main effects were examined.  
Significant univariate main effects for treatment were obtained for mean start latency F(4,57) = 
7.43, p < 0.001, and mean distance traveled F(4,57) = 7.26, p < 0.001.   
  Tukey’s HSD post hoc comparisons revealed a marginally significantly longer mean 
start latency for the anxiety-clonidine group compared to the vehicle no-test group (ps < 0.072).  
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In addition, the post hoc comparisons revealed significantly longer mean start latency for the 
vehicle-depression group compared to the vehicle no-test group and a shorter mean start latency 
for the depression-imipramine group compared to the vehicle-depression group (ps < 0.001).  
Mean distance traveled for the vehicle-depression group was significantly shorter compared to 
the vehicle no-test group, and the mean distance traveled for the imipramine-depression group 
was significantly longer compared to the vehicle-depression group (ps < 0.005).  
25c:75o (Ambiguous Owl Stimulus Cue) 
 The effects of various drug treatment conditions on start and goal latencies and distance 
traveled under the 25c:75o stimulus cue are presented in panels A, B, and C of Figure 11, 
respectively.  In the vehicle no-test group, mean start latencies were relatively short (e.g., chicks 
left the start box in under a minute); whereas, mean goal latencies were relatively long (e.g., 
chicks reached the goal in approximately 5-min; the cutoff criterion).   The mean distance 
traveled for the vehicle no-test group was approximately 21 cm, indicating that although most 
chicks approached the stimulus cue, they did not reach the goal.  Mean start latency for the 
vehicle-anxiety group was somewhat longer compared to the vehicle no-test group, however  
mean goal latency and mean distance traveled did not differ from the vehicle no-test group (ps = 
n.s). Mean start and goal latencies and mean distance traveled for the anxiety-clonidine group did 
not differ from the vehicle no-test group or from the vehicle-anxiety group (ps = n.s.). 
 Mean start latency for the vehicle-depression group was longer compared to the vehicle 
no-test group and this effect was reversed by the depression-imipramine group.  Mean goal 
latency for the vehicle-depression group did not differ from the vehicle no-test group and mean 
goal latency for the depression-imipramine group did not differ from the vehicle-depression 
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group (ps = n.s).  Mean distance traveled for the vehicle-depression group was somewhat shorter 
compared to the vehicle no-test group and this effect was somewhat reversed by the depression-
imipramine group. 
 Consistent with these observations, a one-way MANOVA revealed a significant 
multivariate main effect for treatment, Wilks’ λ = 0.560, F(12,135.23) = 2.76, p < 0.005, where p 
< 0.0125 is considered significant,  partial eta squared = 0.176. Power to detect the effect was 
0.957. Given the significance of the overall test, the univariate main effects were examined.  
Significant univariate main effects for treatment were obtained for mean start latency F(3,31) = 
13.67, p < 0.001, and mean distance traveled F(3,31) = 5.97, p < 0.005.   
 Tukey’s HSD post hoc comparisons revealed a marginally longer mean start latency for 
the vehicle-anxiety group compared to the vehicle no-test group (p = 0.092) Mean start latency 
for the vehicle-depression group was significantly longer compared to the vehicle no-test group 
(p <  0.001), and a shorter mean start latency for the depression-imipramine group compared to 
the vehicle-depression group (ps < 0.05).  Mean distance traveled for the vehicle-depression 
group was shorter compared to the vehicle no-test group (p < 0.005), and the depression-
imipramine group revealed a shorter mean distance traveled compared to the vehicle-depression 
group (p < 0.05) 
0c:100o (Owl Stimulus Cue)   
 The effects of various drug treatment conditions on start and goal latencies and distance 
traveled under the 0c:100o stimulus cue are presented in panels A, B, and C of Figure 12, 
respectively.  In the vehicle no-test group, mean start latencies were relatively short (e.g., chicks 
left the start box in under 30 seconds); whereas, mean goal latencies were very long (e.g., chicks 
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reached the goal in approximately 5-min; the cutoff criterion).   Mean distance traveled for the 
vehicle no-test group was approximately 23 cm, indicating that although most chicks approached 
the stimulus cue, they did not reach the goal. 
 Mean start latency for the vehicle-anxiety group was longer compared to the vehicle no-
test group, however  mean goal latency and mean distance traveled did not differ from the 
vehicle no-test group (ps = n.s). Mean start and goal latencies and mean distance traveled for the 
anxiety-clonidine group did not differ from the vehicle-anxiety group (ps = n.s.). However, mean 
start latency for the clonidine-anxiety group was longer compared to the vehicle no-test group.  
In addition, mean distance traveled for the anxiety-clonidine group was shorter compared to the 
vehicle no-test group.   
 Mean start latency for the vehicle-depression group was longer compared to the vehicle 
no-test group and this effect was reversed by the depression-imipramine group.  Mean goal 
latencies for the vehicle-depression and depression-imipramine groups did not groups did not 
differ from the vehicle no-test group (ps = n.s.).  Mean distance traveled for the vehicle-
depression group was shorter compared to the vehicle no-test group and this effect was 
somewhat reversed by the depression-imipramine group. 
 Consistent with these observations, a one-way MANOVA revealed a significant 
multivariate main effect for treatment, Wilks’ λ = 0.642, F(12,148.45) =2.26, p < 0.05, where p < 
0.0125 is considered significant, partial eta squared = 0.137. Power to detect the effect was 
0.903. Given the significance of the overall test, the univariate main effects were examined.  
Significant univariate main effects for treatment were obtained for mean start latency F(4,58) = 
7.30, p < 0.001, and mean distance traveled F(4, 58) = 4.73, p < 0.005.   
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  Tukey’s HSD post hoc comparisons revealed significantly longer mean start latencies for 
the vehicle-anxiety and the anxiety-clonidine groups compared to the vehicle no-test group (ps < 
0.05).  Mean distance traveled for the anxiety-clonidine group was significantly shorter 
compared to the vehicle no-test group (p < 0.05).  Mean start latency for the vehicle-depression 
group was significantly longer than the vehicle no-test group (p < 0.001), and the mean start 
latency for the imipramine-depression group was significantly shorter compared to the vehicle-
depression group (p < 0.05).  Mean distance traveled for the vehicle-depression group was 
significantly shorter compared to the no-test group (p < 0.005), and the mean distance traveled 
for the imipramine-depression group was marginally longer compared to the vehicle-depression 
group (p =0.062).  
Discussion 
 Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a 
depression-like phase and to test whether those cognitive biases could be pharmacologically 
reversed.  More specifically, testing whether clonidine could reverse the cognitive bias of more 
pessimism observed under the anxiety-like phase.  And also, testing whether imipramine could 
reverse not only the cognitive bias of more pessimism observed under the anxiety-like phase, but 
also the cognitive bias of less optimism observed under the depression-like phase.  Distress 
vocalizations served as the dependent behavioral measure. And, start and goal latency and 
distance traveled served as the dependent measures for the maze.  
Distress Vocalizations 
 The pattern of distress vocalizations is consistent with previous findings in which social 
isolation of chicks produces distress vocalizations, a behavioral response to reinstate social 
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contact, to identify an anxiety-like (panic-like) phase (i.e., first 5-min of isolation) and 
depression-like phase (final 30-60 of isolation) (Sufka et al., 2006).  In addition, these two 
phases have been pharmacologically reversed using prototypic anxiolytic and antidepressant 
drugs.  DVoc rates in the anxiety-like phase were significantly attenuated with the administration 
of clonidine, an anxiolytic (Warnick et al., 2009), and also with imipramine, an antidepressant 
with anxiolytic properties (Sufka et al., 2006).  DVoc rates in the depression-like phase remained 
relatively high with the administration of imipramine, an antidepressant, which prevents the 
onset of behavioral despair and puts the chicks back into a panic-like state (Sufka et al., 2006). 
Mirror Stimulus Cue 
 The vehicle-anxiety group and the anxiety-clonidine group did not reveal any statistically 
significant differences from the vehicle no-test group on mean start and goal latencies and on 
mean distance traveled under the mirror stimulus cue.  These behavioral data are consistent with 
the notion that cognitive bias in an anxiety-like state presents as more pessimistic judgments only 
under ambiguous aversive cues.  The vehicle-depression group displayed significantly longer 
mean start and goal latencies under the mirror stimulus cue compared to the vehicle no-test 
which is consistent with the notion of less optimism. The depression-imipramine group displayed 
significantly shorter mean start and goal latencies compared to the vehicle-depression group 
indicating that the cognitive bias of less optimism was reversed by imipramine.  This finding is 
consistent with imipramine preventing the onset of behavioral despair in the isolation apparatus 
thereby putting chicks back into a panic-like state thus reversing less optimistic behavior under 
the ambiguous appetitive stimulus cue.  In addition, the vehicle-depression group displayed a 
marginally significantly shorter mean distance traveled compared to the vehicle no-test group 
which is consistent with the notion of less optimism.  Further, the depression-imipramine group 
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displayed a marginally significantly longer mean distance traveled compared to the vehicle-
depression group which is consistent with imipramine reversing the cognitive bias of less 
optimism.  
75c:25o (Ambiguous Chick Stimulus Cue) 
 The vehicle-anxiety group did not reveal any statistically significant differences from the 
vehicle no-test group or the anxiety-clonidine group on mean start and goal latencies and on 
mean distance traveled under the 75c:25o (ambiguous chick) stimulus cue.  This finding is 
consistent with the notion that cognitive bias in an anxiety-like state presents as more pessimistic 
judgments to ambiguous aversive cues.  Mean start latency for the anxiety-clonidine group was 
marginally significantly longer compared to the vehicle no-test group.  Although this was an 
unexpected finding, given the large amount of animals that needed to be omitted because of clear 
sedation, we can only infer that the increased mean start latency is due to the sedative properties 
of clonidine where these animals didn’t meet the omission criterion.  
  The vehicle-depression group displayed significantly longer mean start latencies under 
the 75c:25o stimulus cue compared to the vehicle no-test which is consistent with the notion of 
less optimism.  The depression-imipramine group displayed significantly shorter mean start 
latencies compared to the vehicle-depression group indicating that the cognitive bias of less 
optimism was reversed by imipramine.  This finding is consistent with imipramine preventing 
the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a 
panic-like state thus reversing less optimistic behavior under the ambiguous appetitive stimulus 
cue.  In addition, the vehicle-depression group displayed significantly shorter mean distance 
traveled which is consistent with the notion of less optimism.  No significant drug treatment 
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differences were found under mean goal latency which is consistent with previous findings 
which indicate that goal latency may not be a sensitive measure of cognitive bias (Salmeto et al., 
in preparation). Further, the depression-imipramine group displayed significantly longer mean 
distance traveled compared to the vehicle-depression group which is consistent with imipramine 
reversing the cognitive bias of less optimism.  
25c:75o (Ambiguous Owl Stimulus Cue) 
 The vehicle-anxiety group revealed a marginally significant longer mean start latency 
compared to the vehicle no-test group under the 25c:75o (ambiguous owl) stimulus cue.  This 
finding is consistent with the notion of more pessimism.  However, the vehicle-anxiety group did 
not significantly differ from the vehicle no-test group on mean goal latency and mean distance 
traveled.  The anxiety-clonidine group did not produce any significant differences compared to 
the vehicle-anxiety group on mean start and goal latencies or on mean distance traveled.  
 The vehicle-depression group displayed longer mean start latencies under the 25c:75o 
stimulus cue compared to the vehicle no-test which is consistent with the notion of more 
pessimism.  The depression-imipramine group displayed significantly shorter mean start 
latencies compared to the vehicle-depression group indicating that the cognitive bias of more 
pessimism was reversed by imipramine.  This finding is consistent with imipramine preventing 
the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a 
panic-like state thus reversing the cognitive bias of more pessimism observed under the 
ambiguous aversive stimulus cue.  No significant drug treatment differences were found under 
mean goal latency which is consistent with previous findings which indicate that goal latency 
may not be a sensitive measure of cognitive bias (Salmeto et al., in preparation).  In addition, the 
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vehicle-depression group displayed significantly shorter mean distance traveled which is 
consistent with the notion of more pessimism. Further, the depression-imipramine group 
displayed significantly longer mean distance traveled compared to the vehicle-depression group 
which is consistent with imipramine reversing the cognitive bias of more pessimism.  
0c:100o (Owl Stimulus Cue) 
 The vehicle-anxiety group revealed significantly longer mean start latency compared to 
the vehicle no-test group under the 0c:100o (owl) stimulus cue which is consistent with the 
notion of more pessimism.  However, the vehicle-anxiety group did not significantly differ from 
the vehicle no-test group on mean goal latency or on mean distance traveled.  In addition, the 
anxiety-clonidine group did not produce any significant differences compared to the vehicle-
anxiety group on mean start and goal latencies or on mean distance traveled.  However, mean 
start latency for the clonidine-anxiety group was significantly longer compared to the vehicle no-
test group.  In addition, mean distance traveled for the anxiety-clonidine group was shorter 
compared to the vehicle no-test group.  Although these findings were unexpected, given the large 
amount of animals that needed to be omitted because of clear sedation, we can only infer that 
increased mean start latency and a shorter mean distance traveled are due to the sedative 
properties of clonidine where these animals didn’t meet the omission criterion.  
 The vehicle-depression group displayed longer mean start latencies under the 0c:100o 
stimulus cue compared to the vehicle no-test which is consistent with the notion of more 
pessimism.  The depression-imipramine group displayed significantly shorter mean start 
latencies compared to the vehicle-depression group indicating that the cognitive bias of more 
pessimism was reversed by imipramine.  This finding is consistent with imipramine preventing 
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the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a 
panic-like state thus reversing the cognitive bias of more pessimism observed under the 
ambiguous aversive stimulus cue.  No significant drug treatment differences were found under 
mean goal latency which is consistent with previous findings which indicate that goal latency 
may not be a sensitive measure of cognitive bias (Salmeto et al., in preparation).  In addition, the 
vehicle-depression group displayed significantly shorter mean distance traveled which is 
consistent with the notion of more pessimism.  Further, the depression-imipramine group 
displayed a marginally significantly longer mean distance traveled compared to the vehicle-
depression group which is consistent with imipramine reversing the cognitive bias of more 
pessimism.  
General discussion 
Cognitive bias is a phenomenon that presents in individuals suffering from anxiety and/or 
depression in which cognitive disturbances elicit negative interpretations of ambiguous stimuli 
and/or events.  More specifically, anxiety is associated with more pessimistic judgments, 
whereas depression is associated with both more pessimistic judgments and less optimistic 
judgments (Wright & Bower 1992; MacLeod & Byrne 1996).  Interestingly, cognitive bias has 
been shown to be sensitive to a variety of therapies affecting mood disturbances including 
Cognitive Behavioral Therapy (CBT) (Mathews et al., 1995; Mogg et al., 1995; Segal & Gemar, 
1997) and a variety of pharmacotherapies. Following the administration of citrolpam, a serotonin 
selective reuptake inhibitor (SSRI), the negative interpretation biases observed in anxious 
individuals were ameliorated (Mogg et al., 2004; Weinstein & Nutt, 1995). Further, a single dose 
of reboxetine, a norepinephrine selective reuptake inhibitor (NSRI), reversed the negative biases 
observed in depressed individuals (Harmer et al., 2009).  
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 Cognitive bias has previously been examined in the chick anxiety-depression continuum 
model using a measure of approach/avoidant behavior to a range of appetitive to aversive 
stimulus cues in a straight alley maze (Salmeto et al., in preparation).  The observation that 
chicks display cognitive bias in this paradigm following social separation stress serves as an 
important validation step for the model.  The demonstration of reversing the cognitive biases that 
presents under the anxiety- and depression-like phases within the maze would provide a further 
validation of the chick anxiety-depression continuum model as a neuropsychiatric simulation.   
 As previously discussed, Experiment 2 sought pharmacologically reverse the cognitive 
biases observed under an anxiety-like and a depression-like state. Experiment 2 replicated 
previous findings from Salmeto et al. (in preparation) where depressed chicks display the 
cognitive bias of less optimism under the appetitive and ambiguous appetitive cues and the 
cognitive bias of more pessimism under the aversive and ambiguous aversive cues.  These 
findings were observed on start latency and distance traveled.  However, goal latency did not 
prove to be a sensitive measure of cognitive bias which is consistent with previous findings from 
Salmeto et al. (in preparation). Therefore we suggest that for future studies goal latency should 
be discarded and distance traveled, a more sensitive measure, should be included as a dependent 
variable.  Or alternatively, lengthening the runway or the time of the test session within the 
runway may provide more differentiation between and a better analysis of the dependent 
variables.  Further, imipramine reversed both forms of cognitive bias in the depression-like phase 
under start latency and distance traveled. These findings are consistent with the human clinical 
literature in that cognitive biases can be pharmacologically reversed in depressed individuals 
(Harmer et al., 2009). More specifically, the administration of a single dose of reboxetine, a 
norepinephrine selective reuptake inhibitor, can reverse the negative interpretation biases 
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observed within depressed individuals towards emotional information processing or negative 
self-referent information compared to controls (Harmer et al., 2009). 
Despite using lower doses, the inability of clonidine to reverse the cognitive bias in 
anxiety may be related to the sedative nature of the compound.  To try to account for sedation, 
we excluded data from chicks that were overtly drowsy or fully asleep prior to analysis.  This 
resulted in lower sample sizes, an increase in error variance, and a decrease in power to detect 
significant group differences.  Another contributing factor to error variance was the inclusion of 
animals that were probably sedated but did not meet the criterion for exclusion.  Other 
pharmacological options that may be able to reverse the cognitive bias of anxiety include the 
benzodiazepines and serotonin selective reuptake inhibitors (SSRIs).  
In an attempt to separate the therapeutic effects from the sedative effects of the 
benzodiazepine diazepam, Murphy, Downham, Cowen, & Harmer (2008) administered 
diazepam at a single low dose that was clinically effective but did not produce sedation in 
healthy controls. Upon completion of a battery of emotional processing tasks including facial 
expression recognition tasks, attentional dot probe tasks, and startle reflex tasks, among others, 
Murphy et al. (2008) concluded that at non-sedating doses, diazepam did not affect mood but did 
reveal an increase in positive interpretation in healthy controls. However, when using 
benzodiazepine anxiolytics, Golombok et al. (1991) was unable to observe a reversal of negative 
interpretation bias in anxious individuals but did reveal an overall slowing of latencies for color 
naming on the Stroop task.  In addition, Stewart et al. (2000) did not find a reversal of cognitive 
bias in anxious individuals after naturalistic benzodiazepine anxiolytic use (i.e. taken on an “as 
needed basis”). Consistent with the sedative properties observed in the human literature, a study 
by Ennaceur, Michalikova, van Rensburg, & Chazot (2008) revealed that the administration of 
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the benzodiazepines diazepam and chlordiazepoxide produced sedation and did not reduce 
anxiety in mice (Ennaceur et al., 2008).  Thus, benzodiazepines may not be the most appropriate 
anxiolytic compound to reverse the cognitive bias seen in anxiety because sedation would cause 
runway slowing which would be a large confound. However, SSRIs have been shown to reverse 
the cognitive bias of anxiety in the human literature without sedative confounds (Mogg et al., 
2004; Weinstein & Nutt, 1995); therefore, this class of compounds appears to be the most 
appropriate for future research on reversing the cognitive bias in anxiety.  
 Experiment 1 tested the effects of two drug probes on DVoc rates in non-stressed socially 
tested chicks, noting these drug treatment groups have not been used in prior validation studies. 
However, the pattern of drug effects on DVoc rates is similar to that of isolated chicks whereby 
anxiolytics attenuate DVoc rates in the anxiety-like phase and antidepressants elevate the DVoc 
rates in the depression-like phase. This finding suggests that the chicks are exposed to some 
measurable amount of stress.  Early studies suggest that experimenter stress and novelty to an 
apparatus are two major contributing factors to stress which may be mitigated by handling and 
exposure (Feltenstein et al., 2002).   Another contributing factor to stress may have been flock 
reduction (e.g., any number lower than 12).   Further, the observed pattern of drug effects in 
socially tested chicks helps explain the cognitive biases observed under the two ambiguous 
stimulus cues (i.e., 75C:25o and 25o:75c) which were also pharmacologically reversed.  Testing 
drug probes in socially tested chicks has not been examined. This is an avenue of research that 
should be further explored to gain a better understanding of the level of stress induced upon the 
chicks and prevented by the drug probes administered.  
Collectively, the observation that cognitive biases of both more pessimism and less 
optimism present within the single test paradigm of anxiety and depression and can be 
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pharmacologically reversed in the depression-like phase adds to the validity of the chick anxiety-
depression model as a neuropsychiatric simulation. The chick anxiety depression model, along 
with the runway test to ambiguous appetitive and aversive cues, may lend itself to exploring the 
common neurophysiological mechanisms subserving cognitive disturbances and 
pharmacological responses seen in these two seemingly related clinical disorders. 
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Figure Captions 
Figure 1. Diagram and pictures of the Straight alley maze apparatus. 
Figure 2. Morphed stimulus cue conditions that blended elements of a chick and a horned owl 
silhouette which were defined as: 75c:25o; 75c:25o; 0c:100o. (Note: the 100c:0o and the 50c:50o 
will not be used in the current study. They are shown only as a reference). 
Figure 3. Mean distress vocalizations as a rate/minute function (+/- SEM) for each drug 
treatment condition under the anxiety-like and depression-like phases in panels A and B, 
respectively . Sample sizes were n = 28-36. * Indicates a significant decrease compared to the 
vehicle condition. ** Indicates a significant increase compared to the vehicle condition.   
Figure 4. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the mirror stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 9-12, except of the anxiety-clonidine condition where n = 7.  * Indicates 
significantly shorter latencies compared to the vehicle isolation-test condition.  
Figure 5. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 75c:25o stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 9-10, except for the anxiety-clonidine condition where n = 5.  † Indicates a 
significant difference compared to the vehicle no-test condition which is interpreted as less 
optimism.  †† Indicates a significant difference compared to the vehicle isolation-test condition 
which is interpreted as a reversal of less optimism. 
Figure 6. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 25c:75o stimulus cue in panels A, B, and C respectively.  Samples 
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sizes were n = 8-9.  * Indicates a significant difference compared to the vehicle no-test condition 
which is interpreted as more pessimism.  ** Indicates a significant difference compared to the 
vehicle isolation-test condition which is interpreted as a reversal of more pessimism. 
Figure 7. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 0c:100o stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 6-8, except for the depression-imipramine condition where n = 11.  No significant 
differences were found.  
Figure 8. Mean distress vocalizations as a rate/minute function (+/- SEM) for each drug 
treatment condition under the anxiety-like and depression-like phases in panels A and B, 
respectively . Sample sizes were n = 48-54, except for the anxiety-clonidine condition where 
DVocs were collapsed across both isolation treatment conditions resulting in n = 99.  * Indicates 
a significant decrease compared to the vehicle condition. ** Indicates a significant increase 
compared to the vehicle condition.   
Figure 9. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the mirror stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 10-15.  † Indicates a significant difference compared to the vehicle no-test 
condition which is interpreted as less optimism.  †† Indicates a significant difference compared 
to the vehicle-depression condition which is interpreted as a reversal of less optimism. 
Figure 10. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 75c:25o stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 11-15, except for the anxiety-clonidine condition where n = 7.  † Indicates a 
significant difference compared to the vehicle no-test condition which is interpreted as less 
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optimism.  †† Indicates a significant difference compared to the vehicle-depression condition 
which is interpreted as a reversal of less optimism. 
Figure 11. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 25c:75o stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 11-15, except for the anxiety-clonidine condition where n = 6.  * Indicates a 
significant difference compared to the vehicle no-test condition which is interpreted as more 
pessimism.  ** Indicates a significant difference compared to the vehicle-depression condition 
which is interpreted as a reversal of more pessimism. 
Figure 12. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug 
treatment condition under the 0c:100o stimulus cue in panels A, B, and C respectively.  Samples 
sizes were n = 12-15, except for the anxiety-clonidine condition where n = 7.  * Indicates a 
significant difference compared to the vehicle no-test condition which is interpreted as more 
pessimism.  ** Indicates a significant difference compared to the vehicle-depression condition 
which is interpreted as a reversal of more pessimism. 
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Figure 9  
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Figure 10  
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Figure 11 
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Figure 12 
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